Does VALSARTAN Cause Hypophosphataemia? 5 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Hypophosphataemia have been filed in association with VALSARTAN (valsartan). This represents 0.0% of all adverse event reports for VALSARTAN.
5
Reports of Hypophosphataemia with VALSARTAN
0.0%
of all VALSARTAN reports
2
Deaths
4
Hospitalizations
How Dangerous Is Hypophosphataemia From VALSARTAN?
Of the 5 reports, 2 (40.0%) resulted in death, 4 (80.0%) required hospitalization.
Is Hypophosphataemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for VALSARTAN. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does VALSARTAN Cause?
Drug ineffective (1,845)
Blood pressure increased (1,682)
Dizziness (1,527)
Headache (1,361)
Hypertension (1,341)
Acute kidney injury (1,301)
Dyspnoea (1,239)
Fatigue (1,156)
Malaise (1,139)
Hypotension (1,032)
What Other Drugs Cause Hypophosphataemia?
FERRIC CARBOXYMALTOSE (1,046)
ADEFOVIR DIPIVOXIL (368)
DENOSUMAB (322)
ZOLEDRONIC ACID (235)
LAMIVUDINE (205)
CYCLOPHOSPHAMIDE (196)
TENOFOVIR DISOPROXIL (192)
DEXAMETHASONE (186)
ACETAMINOPHEN (169)
LANSOPRAZOLE (159)
Which VALSARTAN Alternatives Have Lower Hypophosphataemia Risk?
VALSARTAN vs VALTREX
VALSARTAN vs VAMOROLONE
VALSARTAN vs VANCOMYCIN
VALSARTAN vs VANDETANIB
VALSARTAN vs VARDENAFIL